688117 圣诺生物
已收盘 12-27 15:00:01
资讯
新帖
简况
圣诺生物上周获融资净卖出3631.66万元,居两市第124位
金融界 · 49分钟前
圣诺生物上周获融资净卖出3631.66万元,居两市第124位
圣诺生物收盘上涨0.15%,滚动市盈率31.71倍
金融界 · 12-27 20:26
圣诺生物收盘上涨0.15%,滚动市盈率31.71倍
圣诺生物:公司募投项目“年产395千克多肽原料药生产线项目”主体建设已经完工
每日经济新闻 · 12-27
圣诺生物:公司募投项目“年产395千克多肽原料药生产线项目”主体建设已经完工
圣诺生物:公司多肽原料药品种的氨基酸数量区间为5-50个
每日经济新闻 · 12-27
圣诺生物:公司多肽原料药品种的氨基酸数量区间为5-50个
圣诺生物:与浙大合作推进美容肽AI预测与研发
金融界 · 12-26
圣诺生物:与浙大合作推进美容肽AI预测与研发
圣诺生物:替尔泊肽原料药及制剂项目目前正处于药学研究阶段
格隆汇 · 12-26
圣诺生物:替尔泊肽原料药及制剂项目目前正处于药学研究阶段
12月26日圣诺生物发布公告,其股东减持32.8万股
证券之星 · 12-26
12月26日圣诺生物发布公告,其股东减持32.8万股
圣诺生物股东乐普医疗累计减持公司88.94万股
智通财经 · 12-26
圣诺生物股东乐普医疗累计减持公司88.94万股
圣诺生物(688117.SH)股东乐普医疗累计减持公司88.94万股
智通财经 · 12-26
圣诺生物(688117.SH)股东乐普医疗累计减持公司88.94万股
成都圣诺生物科技股份有限公司注册资本发生变更
金融界 · 12-26
成都圣诺生物科技股份有限公司注册资本发生变更
圣诺生物12月23日遭主力抛售1061万元 环比增加1133.72%
市场透视 · 12-23
圣诺生物12月23日遭主力抛售1061万元 环比增加1133.72%
圣诺生物收盘上涨0.04%,滚动市盈率33.67倍
金融界 · 12-20
圣诺生物收盘上涨0.04%,滚动市盈率33.67倍
圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务
证券之星 · 12-13
圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务
圣诺生物12月09日获主力加仓229万元 环比增加3171.43%
市场透视 · 12-09
圣诺生物12月09日获主力加仓229万元 环比增加3171.43%
圣诺生物涨5% 生物医药产业受关注
智选洞察 · 12-02
圣诺生物涨5% 生物医药产业受关注
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
汇添富基金 · 11-28
1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会
圣诺生物跌5% 近半年3券商增持
智选洞察 · 11-22
圣诺生物跌5% 近半年3券商增持
概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线
格隆汇 · 11-17
概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线
圣诺生物大跌5.12% 3家券商给予增持建议
智选洞察 · 11-13
圣诺生物大跌5.12% 3家券商给予增持建议
圣诺生物(688117)11月11日主力资金净卖出514.20万元
证券之星 · 11-12
圣诺生物(688117)11月11日主力资金净卖出514.20万元
暂无数据
公司概况
公司名称:
成都圣诺生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2021-06-03
主营业务:
成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。
发行价格:
17.90
{"stockData":{"symbol":"688117","market":"SH","secType":"STK","nameCN":"圣诺生物","latestPrice":26.09,"timestamp":1735282801000,"preClose":26.05,"halted":0,"volume":1312277,"delay":0,"changeRate":0.0015,"floatShares":112000000,"shares":112000000,"eps":0.8228,"marketStatus":"已收盘","change":0.04,"latestTime":"12-27 15:00:01","open":26,"high":26.49,"low":26,"amount":34411300,"amplitude":0.0188,"askPrice":26.1,"askSize":18,"bidPrice":26.09,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.8228,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735522200000},"marketStatusCode":5,"adr":0,"adjPreClose":26.05,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735263000000,1735270200000],[1735275600000,1735282800000]],"highLimit":28.66,"lowLimit":23.45,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":112418556,"isCdr":false,"pbRate":3.19,"roa":"--","peRate":31.708799,"roe":"6.31%","epsLYR":0.63,"committee":-0.083969,"marketValue":2933000000,"turnoverRate":0.0117,"status":0,"afterMarket":{"amount":0,"volume":0,"close":26.09,"buyVolume":0,"sellVolume":0,"time":1735284838975,"indexStatus":"已收盘 12-27 15:30:00","preClose":26.05},"floatMarketCap":2933000000},"requestUrl":"/m/hq/s/688117/tweets","defaultTab":"tweets","newsList":[{"id":"2495555328","title":"圣诺生物上周获融资净卖出3631.66万元,居两市第124位","url":"https://stock-news.laohu8.com/highlight/detail?id=2495555328","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495555328?lang=zh_cn&edition=full","pubTime":"2024-12-30 07:24","pubTimestamp":1735514675,"startTime":"0","endTime":"0","summary":"12月30日,沪深两融数据显示,圣诺生物上周累计获融资净卖出额3631.66万元,居两市第124位,上周融资买入额2586.44万元,偿还额6218.10万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/30072446921566.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2494080290","title":"圣诺生物收盘上涨0.15%,滚动市盈率31.71倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2494080290","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494080290?lang=zh_cn&edition=full","pubTime":"2024-12-27 20:26","pubTimestamp":1735302415,"startTime":"0","endTime":"0","summary":"12月27日,圣诺生物今日收盘26.09元,上涨0.15%,滚动市盈率PE达到31.71倍。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均44.14倍,行业中值27.89倍,圣诺生物排名第97位。截至2024年三季报,共有20家机构持仓圣诺生物,其中基金16家、其他4家,合计持股数6378.56万股,持股市值19.89亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272031199851ae33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412272031199851ae33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2494867061","title":"圣诺生物:公司募投项目“年产395千克多肽原料药生产线项目”主体建设已经完工","url":"https://stock-news.laohu8.com/highlight/detail?id=2494867061","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494867061?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:29","pubTimestamp":1735230591,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:公司IPO“年产395千克多肽原料药生产线项目”什么时候能正式投产?投产后能否承接司美格鲁肽、替尔泊肽、利拉鲁肽等相关GLP-1类药物上游原料订单?圣诺生物(688117.SH)12月26日在投资者互动平台表示,公司募投项目“年产395千克多肽原料药生产线项目”主体建设已经完工,项目的建设工作正稳步推进中,预计于2025年6月达到预定可使用状态,公司将根据信息披露规则及时披露项目进度情况。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700304598505d51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700304598505d51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2494867069","title":"圣诺生物:公司多肽原料药品种的氨基酸数量区间为5-50个","url":"https://stock-news.laohu8.com/highlight/detail?id=2494867069","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494867069?lang=zh_cn&edition=full","pubTime":"2024-12-27 00:26","pubTimestamp":1735230368,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:各位领导好!请问公司的多肽核心品种中是生产的低于10个氨基酸的初级原料产品呢,还是高端长链多肽产品呢?圣诺生物(688117.SH)12月26日在投资者互动平台表示,公司多肽原料药品种的氨基酸数量区间为5-50个,不同长短的多肽的机制和治疗领域有所不同,临床上都能起到较好的治疗作用。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700271798505cb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122700271798505cb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2494855562","title":"圣诺生物:与浙大合作推进美容肽AI预测与研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2494855562","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494855562?lang=zh_cn&edition=full","pubTime":"2024-12-26 18:16","pubTimestamp":1735208191,"startTime":"0","endTime":"0","summary":"公司回答表示:公司于今年10月同浙江大学衢州研究院成立“美容肽创新联合研发中心”,双方将携手推进技术创新、人才培养和科研成果转化。此次与浙江大学衢州研究院的合作,不仅是公司在美容肽领域迈出的重要一步,更是公司致力于科技创新、追求卓越的长远布局。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226182650ab93464f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226182650ab93464f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2494985810","title":"圣诺生物:替尔泊肽原料药及制剂项目目前正处于药学研究阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2494985810","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494985810?lang=zh_cn&edition=full","pubTime":"2024-12-26 18:02","pubTimestamp":1735207337,"startTime":"0","endTime":"0","summary":"格隆汇12月26日丨圣诺生物(688117.SH)于投资者互动平台表示,公司司美格鲁肽原料药及注射液项目目前正处于药学研究阶段,司美格鲁肽原料药已申报美国FDA备案;替尔泊肽原料药及制剂项目目前正处于药学研究阶段。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226180217a20a4863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226180217a20a4863&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2494184858","title":"12月26日圣诺生物发布公告,其股东减持32.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2494184858","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494184858?lang=zh_cn&edition=full","pubTime":"2024-12-26 18:00","pubTimestamp":1735207251,"startTime":"0","endTime":"0","summary":"证券之星消息,12月26日圣诺生物发布公告《圣诺生物:关于持股5%以上股东减持股份结果公告》,其股东乐普(北京)医疗器械股份有限公司于2024年10月31日至2024年11月11日间合计减持32.8万股,占公司目前总股本的0.2929%,变动期间该股股价上涨6.7%,截止11月11日收盘报31.69元。股东增减持详情见下表:根据圣诺生物2024年三季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122600027841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2494783740","title":"圣诺生物股东乐普医疗累计减持公司88.94万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2494783740","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494783740?lang=zh_cn&edition=full","pubTime":"2024-12-26 17:17","pubTimestamp":1735204632,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺生物(688117.SH)发布公告,公司于近日收到乐普医疗出具的《关于股份减持结果的告知函》,截至公告披露日,乐普医疗通过集中竞价方式累计减持公司股份88.94万股,占目前公司总股本的0.7912%。减持后乐普医疗持有公司股份数量为527.2万股,占目前公司总股本的4.6896%,本次减持计划时间已届满。【免责声明】本文仅代表作者本人观点,与和讯网无关。和讯网站对文中陈述、观点判断保持中立,不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考,并请自行承担全部责任。邮箱:news_center@staff.hexun.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226172116984ffb95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226172116984ffb95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0028","BK0201","BK0113","300003","BK0251","BK0114","BK0188","688117","BK0196","BK0042","BK0239"],"gpt_icon":0},{"id":"2494834263","title":"圣诺生物(688117.SH)股东乐普医疗累计减持公司88.94万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2494834263","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494834263?lang=zh_cn&edition=full","pubTime":"2024-12-26 16:48","pubTimestamp":1735202922,"startTime":"0","endTime":"0","summary":"智通财经APP讯,圣诺生物(688117.SH)发布公告,公司于近日收到乐普医疗出具的《关于股份减持结果的告知函》,截至公告披露日,乐普医疗通过集中竞价方式累计减持公司股份88.94万股,占目前公司总股本的0.7912%。减持后乐普医疗持有公司股份数量为527.2万股,占目前公司总股本的4.6896%,本次减持计划时间已届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229604.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0196","BK0188","BK0028","688117","300003","BK0113","BK0239","BK0201","BK0114","BK0251","BK0042"],"gpt_icon":0},{"id":"2494885264","title":"成都圣诺生物科技股份有限公司注册资本发生变更","url":"https://stock-news.laohu8.com/highlight/detail?id=2494885264","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494885264?lang=zh_cn&edition=full","pubTime":"2024-12-26 11:19","pubTimestamp":1735183194,"startTime":"0","endTime":"0","summary":"金融界12月26日消息,据公开信息显示,成都圣诺生物科技股份有限公司近日发生工商变更,公司注册资本由11200万人民币元元变为11241.855600万人民币元元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226112212984fa800&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226112212984fa800&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2493878517","title":"圣诺生物12月23日遭主力抛售1061万元 环比增加1133.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493878517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493878517?lang=zh_cn&edition=full","pubTime":"2024-12-23 15:20","pubTimestamp":1734938420,"startTime":"0","endTime":"0","summary":"12月23日, 圣诺生物股价跌3.25%,报收26.80元,成交金额6160万元,换手率2.03%,振幅3.86%,量比1.74。圣诺生物今日主力资金净流出1061万元,上一交易日主力净流出86万元,今日环比增加1133.72%。|12月23日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|卓翼科技|10.67%|#|小方制药|7.78%|#|威领股份|4.64%|#|蒙娜丽莎|4.32%|#|C博科测试|3.47%|#|爱婴室|3.26%|#|南凌科技|2.82%|#|威奥股份|2.71%|#|晶华微|2.61%|#|潍柴重机|2.53%|圣诺生物所在的化学制药行业,今日主力净流出7.04亿元,行业排名14/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223153833ab8d504c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223153833ab8d504c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2492448648","title":"圣诺生物收盘上涨0.04%,滚动市盈率33.67倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492448648","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492448648?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:44","pubTimestamp":1734698682,"startTime":"0","endTime":"0","summary":"12月20日,圣诺生物今日收盘27.7元,上涨0.04%,滚动市盈率PE达到33.67倍。从行业市盈率排名来看,公司所处的化学制药行业市盈率平均45.84倍,行业中值28.78倍,圣诺生物排名第93位。截至2024年三季报,共有20家机构持仓圣诺生物,其中基金16家、其他4家,合计持股数6378.56万股,持股市值19.89亿元。最新一期业绩显示,2024年三季报,公司实现营业收入3.38亿元,同比16.00%;净利润5694.66万元,同比63.66%,销售毛利率58.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220204845a1fde3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220204845a1fde3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2491329136","title":"圣诺生物:未来如有相关事项且达到披露标准,公司将根据上海证券交易所相关规定及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2491329136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491329136?lang=zh_cn&edition=full","pubTime":"2024-12-13 20:00","pubTimestamp":1734091212,"startTime":"0","endTime":"0","summary":"证券之星消息,圣诺生物12月13日在投资者关系平台上答复投资者关心的问题。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300041297.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2490170767","title":"圣诺生物12月09日获主力加仓229万元 环比增加3171.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490170767","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490170767?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:21","pubTimestamp":1733728877,"startTime":"0","endTime":"0","summary":"12月09日, 圣诺生物股价涨0.44%,报收29.52元,成交金额5937万元,换手率1.78%,振幅2.86%,量比1.07。圣诺生物今日主力资金净流入229万元,上一交易日主力净流入7万元,今日环比增加3171.43%。|12月09日主力加仓幅度前10个股||#|股票简称|主力净额占比|#|申昊科技|6.49%|#|一彬科技|5.87%|#|智能自控|5.30%|#|星德胜|5.21%|#|新瀚新材|5.15%|#|三丰智能|5.04%|#|铭科精技|4.63%|#|惠发食品|4.32%|#|蓝黛科技|4.11%|#|喜悦智行|3.87%|圣诺生物所在的化学制药行业,今日主力净流出1.61亿元,行业排名27/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154332a1dfc8e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209154332a1dfc8e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688117"],"gpt_icon":0},{"id":"2488447846","title":"圣诺生物涨5% 生物医药产业受关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2488447846","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488447846?lang=zh_cn&edition=full","pubTime":"2024-12-02 13:08","pubTimestamp":1733116097,"startTime":"0","endTime":"0","summary":"资金动向截止发稿,圣诺生物获得主力净流出157万元,其中超大单流出17万元,大单流出139万元。主营业务及业绩圣诺生物公司主营业务为多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202130830a265506b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202130830a265506b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["161726","688117","399441","BK0239"],"gpt_icon":0},{"id":"2486387128","title":"1-10月医保统筹收入稳增长,机构:医药后市反转源于三大机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486387128","media":"汇添富基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486387128?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:11","pubTimestamp":1732752682,"startTime":"0","endTime":"0","summary":"消息面上,据医保局日前披露,2024年1-10月医保统筹基金收入23065.07亿元,同比增长8.9%;2024年1-10月统筹支出19165.88亿元,同比增长8.9%。对此,国泰君安表示,1-10月医保统筹基金运行平稳,收入稳健增长,支出增速逐月收窄。国金证券表示,由于多方面因素,医药板块景气度在2021年后经历了长时间的下行。2024年11月7日,国家医保局召开了座谈会,强调了全国统一医保平台和大数据赋能商保发展的重要性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112807590598e4504f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600771","688373","688626","600867","603538","600851","688176","688193","688356","688221","603590","688321","688351","600085","688276","688278","688578","600196","600566","688336","688105","688139","603658","159938","688658","605177","688212","603707","603567","688198","688382","688235","603882","600079","688581","600351","688222","688767","688670","600763","688091","688137","688067","688247","600521","603259","688166","688202","603858","688687","603127","600436","601607","BK0096","688046","600062","688575","603896","600572","688331","688177","688428","688488","BK0188","688389","600529","603392","603439","603456","600252","600422","603939","688050","688192","605199","600329","688076","688073","600380","688271","603367","688117","688189","600056","600285","600721","688114","688301","600488","600080","600276","603087","688062","600332","688180","600998","688315","688520","688506","688163","600055","BK0185","BK0239","600976","603301","688266","688443","603233","600511","600129","BK0012","603309","688690","600211","688656","600420","688617","600200","600535","600739","688029","688566","688085","603108","BK0070","688161","600161","BK0028","688298"],"gpt_icon":0},{"id":"2485284737","title":"圣诺生物跌5% 近半年3券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485284737","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485284737?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:52","pubTimestamp":1732258378,"startTime":"0","endTime":"0","summary":"11月22日,圣诺生物股价大幅下跌,截至14点52分,圣诺生物下跌5.37%,报28.00元/股,成交9123万元,换手率2.83%,振幅5.34%。此外,数据统计显示,近半年内3家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流入394万元,其中超大单流入758万元,大单流出363万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145958a24d3633&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122145958a24d3633&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2484509265","title":"概念掘金 | 司美格鲁肽减肥药正式在中国上市,多家电商平台已上线","url":"https://stock-news.laohu8.com/highlight/detail?id=2484509265","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484509265?lang=zh_cn&edition=full","pubTime":"2024-11-17 14:35","pubTimestamp":1731825344,"startTime":"0","endTime":"0","summary":"市场前景广阔","market":"hk","thumbnail":"https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/06664-7e9dde8e-9f54-49fb-a50c-81a04f916999.jpg?guru_height=853&guru_width=1280"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/1336126","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK0012","BK0196","BK0113","BK0188","BK4588","LU1328615791.USD","BK0132","BK0114","BK0077","300003","LU1064130708.USD","BK0239","LU0405327494.USD","002821","BK0201","688076","LU1064131003.USD","600276","BK0028","LU1093756325.SGD","BK0251","BK0060","BK4532","603456","BK0183","LU2148510915.USD","NVO","BK4585","688117","BK0042","LU1093756168.USD","BK0070","IE00BKVL7J92.USD","300199","LU0154236417.USD","BK4007","01801","LU2488822045.USD","LU0405327148.USD","IE00BZ1G4Q59.USD"],"gpt_icon":1},{"id":"2483324016","title":"圣诺生物大跌5.12% 3家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483324016","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483324016?lang=zh_cn&edition=full","pubTime":"2024-11-13 10:40","pubTimestamp":1731465615,"startTime":"0","endTime":"0","summary":"11月13日,圣诺生物股价大幅下跌,截至10点40分,圣诺生物下跌5.12%,报30.42元/股,成交7195万元,换手率2.05%。此外,数据统计显示,近半年内3家券商给予增持建议,10家券商给予买入建议。资金动向截止发稿,圣诺生物获得主力净流出1626万元,其中超大单流出1580万元,大单流出44万元。最新财报显示,今年三季报,圣诺生物实现营业收入3.38亿元,同比增长16.00%,净利润为5,694.66万元,同比增长63.66%,基本每股收益为0.51元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113104049a23223fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113104049a23223fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688117","BK0239"],"gpt_icon":0},{"id":"2482795729","title":"圣诺生物(688117)11月11日主力资金净卖出514.20万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482795729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482795729?lang=zh_cn&edition=full","pubTime":"2024-11-12 08:16","pubTimestamp":1731370614,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月11日收盘,圣诺生物报收于31.69元,上涨7.75%,换手率6.27%,成交量7.03万手,成交额2.17亿元。近5日资金流向一览见下表:圣诺生物融资融券信息显示,融资方面,当日融资买入2776.37万元,融资偿还2119.77万元,融资净买入656.6万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200006540.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688117","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-03","address":"四川省成都市大邑县晋原镇工业大道一段(工业集中发展区内)","stockEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":-0.0897},{"period":"3month","weight":-0.0287},{"period":"6month","weight":0.0632},{"period":"1year","weight":-0.0115},{"period":"ytd","weight":-0.0676}],"companyName":"成都圣诺生物科技股份有限公司","boardCode":"AI0027","perCapita":"22461股","boardName":"医药制造业","registeredCapital":"11241万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0273},{"period":"3month","weight":0.1012},{"period":"6month","weight":0.1458},{"period":"1year","weight":0.1508},{"period":"ytd","weight":0.1429}],"survey":" 成都圣诺生物科技股份有限公司主营业务是多肽创新药CDMO服务,自主研发、销售的多肽原料药和制剂产品,多肽类产品定制生产服务,以及多肽药物生产技术转让服务。公司主要产品为制剂、原料药、药学研究服务、受托加工服务、定制生产。公司及子公司拥有发明专利32项、实用新型专利30项(其中2项同时取得国际专利)和大量非专利技术,先后获评国家级、省级科研和技术改造项目十余项。","serverTime":1735517596160,"listedPrice":17.9,"stockholders":"5005人(较上一季度减少21.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺生物,688117,圣诺生物股票,圣诺生物股票老虎,圣诺生物股票老虎国际,圣诺生物行情,圣诺生物股票行情,圣诺生物股价,圣诺生物股市,圣诺生物股票价格,圣诺生物股票交易,圣诺生物股票购买,圣诺生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺生物(688117)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺生物(688117)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}